Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, October 26, 2025

Induction of mitochondrial biogenesis enhances neurogenesis and cognitive recovery following ischaemic stroke

 You didn't answer the question; EXACTLY HOW WILL RECOVERY BE GUARANTEED!
Bad research and your doctor and hospital will need to get human testing done.

Do you prefer your doctor, hospital and board of director's incompetence NOT KNOWING? OR NOT DOING?

This might help in getting it done:

Abstract

Purpose

Stroke can cause severe cognitive impairment in patients. Recently, neurogenesis has been proposed as a potential approach to improve cognitive abilities after stroke. However, no effective treatment strategy currently exists for stimulating hippocampal neurogenesis to promote cognitive recovery. Therefore, this study investigated the mechanisms underlying the increase in hippocampal neurogenesis induced by mitochondrial biogenesis.

Methods

To achieve the objective, mice subjected to the global cerebral ischaemia (GCI) model via bilateral common carotid artery occlusion were used to investigate mitochondrial biogenesis in vivo through western blotting, transmission electron microscopy, and immunofluorescence staining. Hippocampal neurogenesis was assessed using immunofluorescence staining. Cognitive functions were evaluated using the open field test, novel object recognition, fear conditioning, and Morris water maze. In addition, an in vitro oxygen–glucose deprivation model served as a stroke analogue. Neurite outgrowth in primary neurons was quantified using immunofluorescence staining, while mitochondrial function parameters, including adenosine triphosphate, mitochondrial membrane potential, and reactive oxygen species, were measured using specific assay kits. Lentiviruses were used to manipulate mitochondrial biogenesis both in vivo and in vitro.

Results

We observed that the time course of mitochondrial biogenesis matched that of neurogenesis in the hippocampal dentate gyrus (DG) following GCI. Promoting mitochondrial biogenesis enhanced neurogenesis in the DG, lengthened neurites, and improved mitochondrial function, collectively alleviating cognitive deficits following stroke. Conversely, inhibition of mitochondrial biogenesis had the opposite effect. In addition, ubiquinol-cytochrome c reductase core protein 1 (UQCRC1) was identified as a crucial component of mitochondrial biogenesis(How was it delivered and the amounts?). UQCRC1 knockdown impaired neurogenesis and cognitive abilities in mice.

Conclusion

This study highlights that mitochondrial biogenesis plays a pivotal role in neurogenesis within the hippocampal DG and may represent a promising strategy for treating cognitive impairment associated with ischaemic stroke.

Graphical Abstract

No comments:

Post a Comment